Nisihara T, Ushio Y, Higuchi H, Kayagaki N, Yamaguchi N, Soejima K, Matsuo S, Maeda H, Eda Y, Okumura K, Yagita H
The Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan.
J Immunol. 2001 Sep 15;167(6):3266-75. doi: 10.4049/jimmunol.167.6.3266.
Fas ligand (L)/CD95L, a proapoptotic member of the TNF family, is a potential target for clinical intervention in various diseases. In the present study, we generated a humanized anti-human FasL mAb and characterized the epitopes of neutralizing mAbs by extensive alanine-scanning mutagenesis of human FasL. The predicted molecular model of FasL trimer revealed that the mAbs recognize largely overlapped conformational epitopes that are composed of two clusters, one around the outer tip-forming D-E loop and another near the top of FasL. Both of these sites on FasL are critically involved in the direct interaction with the corresponding receptor, Fas. These results suggest that the mAbs efficiently neutralize FasL cytotoxicity by masking both of these FasL/Fas contact sites.
Fas配体(L)/CD95L是肿瘤坏死因子家族的一种促凋亡成员,是各种疾病临床干预的潜在靶点。在本研究中,我们制备了一种人源化抗人FasL单克隆抗体,并通过对人FasL进行广泛的丙氨酸扫描诱变来表征中和性单克隆抗体的表位。FasL三聚体的预测分子模型显示,这些单克隆抗体识别的构象表位在很大程度上相互重叠,这些表位由两个簇组成,一个围绕形成外尖端的D-E环,另一个靠近FasL顶部。FasL上的这两个位点都关键地参与了与相应受体Fas的直接相互作用。这些结果表明,这些单克隆抗体通过掩盖这两个FasL/Fas接触位点有效地中和了FasL的细胞毒性。